In September 2024, the United Nations will hold the second High-Level Meeting on Antimicrobial Resistance (AMR) to coordinate global action against this growing global health threat. While TB accounts for a significant proportion of AMR-related deaths and drug resistance is a major driver of the TB burden, drug-resistant TB is largely overlooked in the broader AMR agenda. It is clear that no effort to end TB will be successful without a robust AMR response and no AMR response will be complete without ending TB.

This webinar explores the connections between TB and AMR, and will call on the inclusion of TB within the AMR agenda. Speakers highlight some of the challenges and opportunities that exist in addressing the leading infectious disease killer, while mitigating the increasing risk of drug resistance.

Speakers include:

• Himanshu Patel: MDR-TB Survivor

• Janika Hauser: Director, Campaigns in Global Health

• Dr. Giorgia Sulis: Canada Research Chair in Communicable Disease Epidemiology and Assistant Professor, University of Ottawa

• Dr. Ryan Cooper: Infectious Disease Physician and Head of the Alberta TB Program

• Dr. Cherise Scott: Senior Strategy Manager, Unitaid

Watch here: https://www.youtube.com/watch?v=QHWnmAzAqIw